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Abstract 
  BACKGROUND:  Atherosclerosis  is  the  most  important  underlying  cause  of  cardiovascular 
diseases (CVD) which recently has been classified as an inflammatory disorder. Accumulation of 
large amounts of oxidized LDL in the intima during local inflammation reaction led to increase 
several factors such as C  reactive protein (CRP). It has also been reported that CRP is able to 
bind  with  modified  forms  of  LDL  as  well  as  oxidized  LDL.  These  findings  suggest  possible 
positive  or  negative  involvement  of  this  protein  in  atherogenesis.  The  main  objective  of  the 
present study was to assess the influence of CRP on LDL oxidation and the possible physical 
\changes of LDL in the presence of CRP in vitro. 
  METHODS:  In  this  study,  the  susceptibility  of  purified  LDL  to  oxidation  was  assayed  by 
monitoring of formation of conjugated dienes in different physiological concentrations of CRP 
(0   0.5  2   g/ml) using a shimadzu spectrophotometer. Electrophoresis was used to determine 
the electrophoretic mobility of LDL in those conditions. 
  RESULTS: CRP significantly reduced the susceptibility of Cu++  induced LDL oxidation through 
increasing  the  lag  timeand  there  was  positive  relationship  between  these  findings  and  CRP 
concentration (P < 0.05). CRP caused a significant reduction in the electrophotretic mobility of 
LDL compared to native LDL (n LDL) (P<0.05). 
  CONCLUSION: A considerable reduction was shown in LDL oxidation, in higher concentration 
of  CRP,  via  an  unknown  mechanism.  The  electrophoretic  mobility  of  LDL,  in  the  oxidative 
condition, decreases in the presence of CRP compared to n LDL, which can be indicative of the 
effect  of  this  protein  on  the  physical  and  chemical  properties  of  LDL.  It  seems  that,  other 
pathway than LDL oxidation is responsible for the effect of CRP on the atherogenesis processes. 
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Introduction 
Coronary Artery Disease (CAD) is one of the most 
common  causes  of  death  worldwide  and 
atherosclerosis  has  been  identified  as  its  main 
underlying cause.1 Atherosclerosis is the formation of 
fibrous lesions and fatty streaks in vessels, which is 
associated with inflammation.2 Thus far, researchers 
studying various factors suspected of triggering this 
pathological  process  have  achieved  valuable  results, 
however,  as  yet  no  specific  pathogenic  process  has 
been identified as the initiating point in the process of 
atherogenesis  in  vessels  and  all  our  information 
consider it to have a multifactorial nature caused by 
an  interplay  of  linked  pathological  mechanisms.3 
Those responsible for LDL oxidation consider as the 
most  important  pathological  processes.  Ox LDL  is 
the  end  product  of  LDL  oxidation  in  the  blood, 
which  is  highly  destructive  atherogenic.  Ox LDL  is 
one of the principal triggers of inflammatory reactions 
in  vascular  endothelial  cells  which  stimulate  the 
secretion  of  cellular  inflammatory  markers.4  During 
the past years, extended studies have been conducted 
to  identify  the  factors  involved  in  oxidation  and 
modification of lipoproteins, especially LDL. Some of 
these  studies  have  focused  on  inflammatory 
markers.1 5  Level  of  these  markers  increase  during 
inflammatory  process  and  it  is  suggested  that  they 
may be involved in atherogenesis.6 Effect of CRP on Some of The In vitro Physicochemical Properties of LDL 
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  In some studies, the interaction of some of these 
markers  and  LDL  has  been  reported,  including  in  a 
study which reported CRP binding with modified forms 
of LDL; it was even observed that it binds with native 
LDL .7Nunomura et al. in 1990 demonstrated that this 
interaction probably occurs via apolipoprotein B in LDL 
at  phosphorylcholine  binding  site  of  CRP.8  The 
mechanism activated by CRP through this binding and 
its  nature  (positive  or  negative)  remains  a  matter  of 
debate. The findings of previous studies in this field are 
controversial.9 12  Therefore,  this  study  attempted  to 
address one of the challengeable aspects of CRP. It was 
assumed  that  CRP  influences  LDL  oxidation  after 
binding  with  it  and  affects  some  of  its  physical 
properties.  Our  study  showed  that  CRP  can  induce 
various properties in relation with LDL. For example, it 
was observed that it reduced the susceptibility of LDL 
to oxidation and decreased the electrophoretic mobility 
of  oxidized  LDL.  In  general,  finding  the  relationship 
between  these  effects  and  the  atheorgensis  process 
warrants further studies in this field. 
Materials and Methods 
1) Blood sample collection; In the beginning, a 100 
ml sample of a healthy man’s blood was prepared and 
centrifuged at 3000 rpm for 15 minutes.  
2)  LDL  purification;  LDL  was  extractedseparated 
from the fresh serum using a Beckman coulter optima 
L 100XP  ultracentrifuge,  with  a  two stage 
ultracentrifugation technique described by Bronzert & 
Brewer  in  the  specific  concentration  gradients  at 
60000 rpm for 6 and 12 hours respectively, at 16 °C 
[13].  
3)  LDL dialysis; The obtained  LDL  was  carefully 
poured into a Sigma Aldrich® dialysis tube and after 
closing  both  ends  of  the  tube,  it  placed  in  a  dish 
containing  PBS  buffer  (i.e.  16.7  mM  sodium 
dihydrogen  phosphate  dihydrate  and  21.1  mM 
sodium  phosphate  dibasic  in  160  mM  sodium 
chloride with a pH of 7.4) for 24 hours at 6 °C on an 
electric shaker in a dark room.  
4)  Determining  protein  concentration  (Lowry 
method); To conduct the later stages of the study, 
the  concentration  of  LDL  protein  was  measured 
using Lowry’s standard method.14 
5) Oxidation of LDL; The susceptibility of LDL to 
oxidation  was  detected  using  a  standard 
spectrophotometric  method.  Shimadzu 
spectrophotometer  UV  3100  was  used  to  monitor 
formation  of  conjugated  dienes  based  on  the 
technique proposed by Esterbauer and his colleagues 
at  the  wavelength  of  234  nm.15  At  first,  control 
sample containing 20  g protein/ml of LDL and 5 
 M  copper  sulphate  in  PBS  buffer,  pH=7.4  in  a 
quartz  cuvette  was  monitored,  then  test  samples 
which  in  addition  to  contents  mentioned  in  the 
control sample contained 0.5  g/ml and 2  g/ml of 
CRP  were  assessed  with  the  same  technique 
respectively (All the experiments were repeated three 
times,  data  were  analyzed  using  student’s  t test  by 
PRISM© 5). 
6)  Electrophoresis;  Electrophoretic  mobility  of 
normal  LDL  (~10   g  protein  in  a  10   l  sample) 
compared to LDL incubated with CRP (~2.5  g/ml), 
also ox LDL which obtained by incubating of LDL 
(~10  g protein in 10  l sample) with 5  M copper 
sulphate compared to ox LDL incubated with CRP 
(~2.5   g/ml)  in  1%  agarose  gel  (AGE). 
Electrophoresis was performed for 150 min at 90 V 
in 0.05 M barbital buffer, then migrated LDLs were 
fixed in the gel with methanol: water: glacial acetic 
acid (6:3:1) and finally stained by 0.1 % fatRed 7B in 
methanol, which just before use should be mixed with 
0.1 N NaOH. 
Results 
Initially,  CRP  in  the  concentration  of  0.5   g/ml 
reduced the susceptibility of LDL (20  g protein/ml) 
to oxidation through increasing the lag time and when 
its concentration reached 2  g/ml, it nearly inhibited 
LDL oxidation in the defined time (Figure 1). Other 
oxidation  parameters  such  as  maximal  amount  of 
dienes  formed  (diene  (max)(,  maximal  rate  of 
oxidation  (maximal  rate)  and  time  need  to  reach 
maximal  amount  of  dienes  (t  (max))  in  CRP  (0.5 
 g/ml) incubated  LDL  samples  compared  to  equal 
parameters in alone LDL samples, had no significant 
statistical differences (P > 0/05). On the other hand, 
maximal  rate  of  oxidation  in  CRP  (2   g/ml)   
incubated  LDL  samples,  had  significant  difference 
with  LDL  samples  without  CRP  (P<0.05).  Other 
oxidation  parameters  in  the  latter  concentration  of 
CRP were not detectable in the time frame (Figure 1 
and Table 1). 
  In  figure  2,  the  single  LDL  bond  which  was 
separated  using  ultracentrifuging  method  is  shown. 
The  single  bond  indicates  the  purity  of  separated 
LDL,  without  any  contamination  with  other 
lipoproteins.  
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Figure  1.  Inhibition  of  LDL  oxidation  is  proportionate  with  increased  CRP  concentration.  The  curves  represent  the 
susceptibility  of  LDL  to  oxidation  at  the  concentration  of  20   g  protein/ml,  in  presence  of  different  physiologic 
concentrations of CRP. In 0.5  g/ml of CRP (●), susceptibility of LDL to oxidation (copper sulphate concentration: 5 M) 
relatively reduced through increasing the lag time, and when CRP concentration reached 2  g/ml (▲), the oxidation of 
LDL was inhibited in the time frame (Data points are mean of three measurements. Significance between lag times were 
analyzed using student’s t test and were significant (P < 0.05). In table 1, various quantative kinetic parameters, associated 
with steps of oxidation of LDL in the presence and absence of CRP have shown. The data which obtained from the 
findings of figure 1 show; lag time, maximal rate of oxidation, time need to reach maximal amount of dienes and maximal 
amount of dienes formed. In lower concentration of CRP, the differences were significant only in lag time, but in higher 
concentration of CRP, because of sizable inhibition of oxidation, only maximal rate was detectable in the time frame and its 
difference was significant, other parameters were not detectable. 
 
Table 1. Quantative parameters of oxidation of LDL 
CRP 
(µg/ml) 
Lag Time 
(min) 
Maximal Rate 
(µM/min) 
t (max) 
(min) 
Diene (max) 
(A234 nm) 
0 
0.5 
2 
55 ± 5 
95 ± 7 * 
Unknown in the time 
frame 
0.115 ± 0.009 
0.136 ± 0.011 
0.008 ± 0.005 * 
155 ± 5 
170 ± 8 
Unknown in the time 
frame 
0.3 ± 0.01 
0.28 ± 0.02 
Unknown in the time 
frame 
 
Values are shown as mean ± SD 
*Significantly different from mean values of samples which contain 0  g/ml CRP, according to student’s t test  
(P < 0.05). 
 
 
                                              Origin ( ) 
 
 
Figure  2.  Electrophoresis  of 
isolated  LDL  is  indicator  of 
purity of LDL (~10  g protein 
in a 10  l sample). It performed 
in 1% Agarose gel at 90  volts 
during  150  minute,  then 
staining process performed with 
FatRed 7B. 
 
 
 
 
According to Figure 3, the LDL (~10  g protein in a 
10  l sample) which was kept in the presence of CRP 
for 18 hours (number1) only had a relatively reducecd 
electrophoretic mobility (reduced REM) compared to 
LDL alone (number 2). LDL which was incubated in 
the presence of CRP and oxidative factor, i.e., 5 M 
Cuso4  for  18  hours  (number  3)  showed  significant 
reduction  in  electrophoretic  mobility  (considerable 
reduced  REM)  compared  to  LDL  which  only 
incubated  with  copper  ion  in  the  same  incubation 
time (number 4), which can be due to reducing of 
negative charge on the surface of ox LDL particle in 
the presence of CRP. 
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Origin ( ) 
 
(+) 
Figure 3. Electrophoresis of incubated samples of LDL 
and CRP in Agarose gel 
 
Discussion 
Pentameric acute phase reactant protein or CRP is a 
sensitive  risk  marker  of  cardiovascular  diseases,  as 
confirmed  by  recent  studies  .17,18  However,  the 
possible role of CRP in atherogenesis as a risk factor 
or even a useful factor with antiatherogenic properties 
is  still  questionable  which  can  be  seen  in  the 
occasionally contradictory results of previous studies 
.9 12,19 The present study shows that CRP is able to 
inhibit  the  invitro  oxidation  of  LDL  in  a  direct 
relationship  with  concentration,  Nonetheless  the 
biochemical mechanism whereby this protein shows 
this ability is not clear. The result of electrophoresis in 
this  study  shows  that  the  LDL  which  was  in  the 
presence of the oxidant copper cation and CRP, had 
less  electrophoretic  mobility  than  LDL  which  was 
only in the presence of copper cation. This may be 
due  to  the  fact  that  CRP  has  conferred  new 
physicochemical properties on semi oxidized LDL by 
binding to it and decreases its negative surface charge 
and consequently reduces its electrophoretic mobility. 
This  latter  conclusion  is  consistent  with  the  recent 
findings of Zwaka et al. and Paceri et al. that CRP can 
facilitate  the  phagocytosis  of  semi oxidized  LDL 
through  macrophages  which  ultimately  leads  to 
formation of atherogenic foam cells.9,11 13 The results 
of this study which are indicative of relative reducing 
in  negative  surface  charge  of  LDL  particle  in  the 
presence of CRP, are in line with the results of a study 
conducted by Rufail et al. It is noteworthy that in that 
study, the result of electrophoresis was obtained only 
after 2 hours of incubation, but in the present study, 
this  period  was  extended  to  18  hours.19  It  can  be 
explained  that  possibly  this  protein  participates  in 
atherogenesis  through  a  mechanism  leading  to 
conformational  changes  in  the  semi oxidized  LDL 
molecule. 
  The results of this study are consistent with recent 
studies which have highlighted a kind of relationship 
and physical binding between CRP and Ox LDL.7,8,20 
It is possible that binding of CRP to some areas of 
the LDL particle (like, phosphocholine moiety) leads 
to some changes on the surface of this lipoprotein, 
resulting in reducing of susceptibility of LDL to more 
oxidation  in  addition  to  preparing  this  modified 
lipoprotein  for  phagocytosis  by  macrophage 
receptors. 
  In the present study, different level of CRP within 
its physiological range in serum were used to assess 
the  degree  to  which  LDL  oxidation  would  be 
influenced in progressive concentrations (0  g/ml, 0.5 
 g/ml  and  2   g/ml  CRP)  because  according  to 
previous studies, it has been clearly demonstrated that 
the  elevated  level  of  CRP  is  related  to  higher 
incidence of cardiovascular disease (17, 18, 22). It is 
notable that the results of some recent studies have 
shown that vascular endothelial cells are prompted by 
a  number  of  trigger  factors  to  secrete  CRP22  this 
finding can form a basis for the hypothesis that this 
protein  may  be  dispatched  to  the  external  space, 
where LDL is invaded by oxidative factors. Also one 
could  hypothesize  that  LDL,  which  in  the  initial 
stages of oxidation induces CRP secretion, indirectly 
recalling this protein towards itself to resist invading 
factors. Based on the result of this study, maybe the 
processes  hypothetically  ascribed  to  CRP  be 
inherently  conducive  to  vascular  health  and  this 
protein  may  have  antiatherogenic  properties  by 
providing  relative  protection  for  LDL  against 
oxidation, but it must be borne in mind that it may be 
possible that, under acute conditions,it act to expedite 
atherogenesis (such as; cooperation with macrophages 
to form foam cells). This second hypothesis may be 
more compatible with the fact that the level of CRP 
increases during cardiovascular diseases.9,11,12,19 
Conclusion 
Overall,  the  effect  of  CRP  on  the  atherogenesis 
processes may pass through a pathway other than LDL 
oxidation ,indepenently from the mechanism whereby 
LDL oxidation is inhibited. More comprehensive studies 
should be done to determine whether CRP has a truly 
conspicuous  role  in  atherogenesis  and  inflammatory 
abnormalities or not . 
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